3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
5
Pain, Postoperative
4
Prostatic Neoplasms
3
Postoperative Hemorrhage
2
Neoplasms
2
Kidney Neoplasms
2
Delirium
2
Central Nervous System Diseases
2
Brain Neoplasms
2
Thyroid Neoplasms
1
Thromboembolism
1
Surgical Wound Infection
1
Spondylitis, Ankylosing
1
Sleep Deprivation
1
Skin Neoplasms
1
Skin Diseases
1
Seroma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Postoperative Shivering
1
Pleural Effusion, Malignant
1
Pituitary Neoplasms
1
Pituitary Diseases
1
Ovarian Neoplasms
1
Neuroinflammatory Diseases
1
Neurocognitive Disorders
1
Neoplasms, Fibrous Tissue
1
Neoplasms, Connective and Soft Tissue
1
Neoplasms, Connective Tissue
1
Neoplasms by Site
1
Neoplasms by Histologic Type
1
Interventions
Sodium Chloride
1
Fluorouracil
1
Carboplatin
1
Botulinum Toxins, Type A
1
Aspirin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Neoplasms by Site
×
Sodium Chloride
×
Clear all
NCT01427400
2016-07-29
Botox
University of British Columbia
Phase 4
Unknown
128 enrolled